Navigation Links
Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival
Date:6/22/2009

ms of overall survival, which is considered to be the gold standard in terms of evaluating efficacy.

About Epeius Biotechnologies

Rexin-G is commercially available for the treatment of all solid tumors in the Republic of the Philippines, and has "fast track status" as a treatment for pancreatic cancer in the United States. Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its high-performance gene delivery systems. To learn more about ongoing clinical trials, licensing and corporate partnering opportunities, please contact Dr. Erlinda M. Gordon at egordon@epeiusbiotech.com.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Epeius Biotech
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sparta Systems Unveils TrackWise(R) Clinical Quality Management Solution
2. China Pharma Holdings, Inc. Announces SFDA Approval for Rosuvastatin Clinical Trials
3. Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite
4. Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
5. CenterWatch to Introduce Key Findings from Surveys on Physician Referrals to Clinical Trials and Clinical Trial Volunteer Experiences at DIA Meeting
6. Microsoft to Showcase Clinical Trial Solutions From Discovery to Approvals at Drug Information Associations 2009 Annual Meeting
7. Zysolin(TM) Pre-clinical Data Supports Once-a-day Dosing in Humans
8. Digital Mammography and Clinical Review Display Units Energising the European Markets for Medical Imaging Display Monitors, Finds Frost & Sullivan
9. Bariatric Advantage High Protein Meal Replacement Clinical Study Presented at European Congress on Obesity
10. International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials
11. Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... September 01, 2014 Currently, scientists ... effective treatments for Alzheimer's disease (AD), which reflects ... exist regarding the diagnosis of the disease, especially ... of appropriate diagnostic tests. In 2014, after ... greatest breakthroughs in the medicine world, there are ...
(Date:9/1/2014)... "Women struggle with weight gain typically associated ... as early as 15, if not earlier. Women ... and downs of hormone related weight gain. The ... seems to rage against the hidden and ever-present hormones ... 40's begin to face menopause and related changes, these ...
(Date:9/1/2014)... fruit consumption cuts the risk of cardiovascular disease (CVD) ... ESC Congress today by Dr Huaidong Du from Oxford, ... of nearly 0.5 million people in the China Kadoorie ... more their risk of CVD declined. , Dr Du ... is the leading cause of death worldwide. Improving diet ...
(Date:9/1/2014)... D.C. (PRWEB) September 01, 2014 The ... pleased to announce that Dawn Bazarko, DNP, MPH, RN, ... Fellows of the American Academy of Nursing. They will ... MBA, RN-BC, CCM, FACHE, whose induction we reported last ... October 18, 2014, during the 2014 American Academy of ...
(Date:9/1/2014)... honor of National Take Your Cat to the Vet Day, which ... Minnesota (AERC) is offering a few reasons why pet owners should ... don’t take their cat to the vet because “there’s nothing wrong” ... not to take their kid to dentist because he or she ... Just like people want their loved ones to be healthy, they ...
Breaking Medicine News(10 mins):Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 3Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Fruit consumption cuts CVD risk by up to 40 percent 2Health News:Fruit consumption cuts CVD risk by up to 40 percent 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3
... , THURSDAY, Oct. 6 (HealthDay News) -- The United ... larger pool of elderly, poor and minority patients than ... says. While elderly black Americans constitute nearly 7 ... hospitals, they make up 15 percent of patients among ...
... Administration and the National Institutes of Health today announced ... monitor and assess the behavioral and health impacts of ... Tobacco Control Act National Longitudinal Study of Tobacco Users, ... research since Congress granted FDA the authority to regulate ...
... release is available in German . ... We guarantee compliance with these norms with our willingness to ... This behavior goes against our own economic self-interest and requires ... Innovative combination of methods , In collaboration with Professor ...
... alliance of Heidelberg University Hospital and the German ... colleagues of the Helmholtz Center for Environmental Research ... which makes malignant brain tumors (gliomas) more aggressive ... inhibit this metabolic pathway is a new approach ...
... has announced today it is entering the next phase ... that would rapidly measure an individual,s level of exposure ... nuclear incident. The project will enter a ... $35.44 million project funded by the U.S. Department of ...
... Reporter , WEDNESDAY, Oct. 5 (HealthDay News) -- Treating ... cancer using Herceptin and chemotherapy, while not ... an anthracycline, improves survival while posing less danger to ... regimens, one of which did not include any anthracyclines. ...
Cached Medicine News:Health News:More Evidence Minorities in U.S. Get Poorer Hospital Care 2Health News:More Evidence Minorities in U.S. Get Poorer Hospital Care 3Health News:FDA and NIH announce joint study on tobacco use and risk perceptions 2Health News:How fair sanctions are orchestrated in the brain 2Health News:Dioxin-like chemical messenger makes brain tumors more aggressive 2Health News:ASU embarks on next phase of an effort to rapidly assess radiation dose 2Health News:Drug Combo Might Fight Aggressive Breast Cancer More Safely 2Health News:Drug Combo Might Fight Aggressive Breast Cancer More Safely 3
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research Report ... 2009-2019 is a professional and in-depth market survey ... industry . The report firstly reviews the basic ... application and manufacturing technology. The report then explores ... Scanner listing their product specification, capacity, Production value, ...
(Date:8/29/2014)... YORK , Aug. 29, 2014 Pomerantz ... TMS S.A. ("EDAP" or the "Company") (NASDAQ: EDAP ... filed in United States District Court, Southern District of ... 14-cv-6069, is on behalf of a class consisting of ... February 1, 2013 and July 30, 2014, inclusive (the ...
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the nation,s ... Polaris Medical Imaging, a leader in sales, service and ... acquisition allows BC Technical to continue to expand their ... MR and CT modalities. "We are ... Mark Alvarez , president and CEO of BC ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3BC Technical Acquires Polaris Medical Imaging 2
... that it received $2.5 million from AstraZeneca AB pursuant to the September 2009 amendment of the exclusive ... indications. , ... , ... ...
... , ... ... - Spasticity Affects a Significant Number of Post-Stroke Patients,[1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4] , ... , , ...
Cached Medicine Technology:Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca 2First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 2First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 3First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 4First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 5First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 6First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 7First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 8First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 9
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Girard straight tying forceps made of titanium has straight shafts with 6 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 105 mm....
McPherson curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 85 mm....
McPherson straight tying forceps made of titanium, straight shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 87 mm....
Medicine Products: